GRIN2B Antikörper (Ser1303)
Kurzübersicht für GRIN2B Antikörper (Ser1303) (ABIN2141178)
Target
Alle GRIN2B Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- Ser1303
-
Immunogen
- GRIN2B antibody was raised in Rabbit using synthesized non-phosphopeptide derived from human GRIN2B around the phosphorylation site of Ser1303 as the immunogen
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- WB: 1:500-1:1000, IHC: 1:50-1:100, ELISA: 1:40000
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Konzentration
- Lot specific
-
Buffer
- PBS (without Mg2+ and Ca2+), pH 7.4, 150 mM NaCl, 0.02 % sodium azide and 50 % glycerol
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handhabung
- Store at -20 °C for 1 year
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Store at -20 °C for 1 year
-
-
- GRIN2B (Glutamate Receptor, Ionotropic, N-Methyl D-Aspartate 2B (GRIN2B))
-
Andere Bezeichnung
- GRIN2B
-
Pathways
- Response to Growth Hormone Stimulus, Synaptic Membrane, Feeding Behaviour, Regulation of long-term Neuronal Synaptic Plasticity
Target
-